{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T11:18:40Z","timestamp":1791371920989,"version":"4.3.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","award":["2022YFE0108400"],"award-info":[{"award-number":["2022YFE0108400"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32372580"],"award-info":[{"award-number":["32372580"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Haihe Laboratory of Sustainable Chemical Transformations"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The ryanodine receptor (RyR) is a critical drug target, yet dantrolene (DAN) remains the only FDA-approved inhibitor, limited by hepatotoxicity and unsuitable for chronic use. To guide improved inhibitor development, we determine high-resolution crystal structures of the RyR Repeat12 (R12) domain bound to DAN, its analog azumolene (AZU), and adenine nucleotides (AMP-PCP or ADP). DAN\/AZU and nucleotides bind cooperatively to a pseudosymmetric cleft, with key interactions involving Trp880 and Trp994. Binding induces a clamshell-like closure of the R12 domain. Isothermal titration calorimetry (ITC) reveals higher affinity in the presence of nucleotides and lower affinity for RyR2 due to nearby substitutions. Structural comparison with cryo-EM data suggests that DAN\/AZU binding allosterically influences RyR gating and functional regulation. Structure-based screening identifies a potent compound targeting the same site but with a distinct binding mode. Our findings highlight the power of domain-focused crystallography in guiding RyR inhibitor discovery and overcoming cryo-EM resolution limitations.<\/jats:p>","DOI":"10.1038\/s41467-025-65096-1","type":"journal-article","created":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T13:20:24Z","timestamp":1763472024000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Crystal structures of Ryanodine Receptor reveal dantrolene and azumolene interactions guiding inhibitor development"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1025-195X","authenticated-orcid":false,"given":"Hadiatullah","family":"Hadiatullah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianyun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajamanikandan","family":"Sundarraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinru","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5005-9698","authenticated-orcid":false,"given":"Nagomi","family":"Kurebayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3992-1889","authenticated-orcid":false,"given":"Takuya","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4368-4794","authenticated-orcid":false,"given":"Toshiko","family":"Yamazawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0793-2391","authenticated-orcid":false,"given":"Yu Seby","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenlan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxia","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiqing","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3845-2980","authenticated-orcid":false,"given":"Takashi","family":"Murayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2728-8537","authenticated-orcid":false,"given":"Filip","family":"Van Petegem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2595-9106","authenticated-orcid":false,"given":"Zhiguang","family":"Yuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,18]]},"reference":[{"key":"65096_CR1","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1016\/j.bbamcr.2018.07.011","volume":"1865","author":"A Kushnir","year":"2018","unstructured":"Kushnir, A., Wajsberg, B. & Marks, A. R. Ryanodine receptor dysfunction in human disorders. Biochim Biophys. Acta 1865, 1687\u20131697 (2018).","journal-title":"Biochim Biophys. Acta"},{"key":"65096_CR2","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1146\/annurev-genet-120417-031311","volume":"52","author":"R Pancaroglu","year":"2018","unstructured":"Pancaroglu, R. & Van Petegem, F. Calcium channelopathies: structural insights into disorders of the muscle excitation\u2013contraction complex. Annu. Rev. Genet. 52, 373\u2013396 (2018).","journal-title":"Annu. Rev. Genet."},{"key":"65096_CR3","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/339439a0","volume":"339","author":"H Takeshima","year":"1989","unstructured":"Takeshima, H. et al. Primary structure and expression from complementary DNA of skeletal muscle ryanodine receptor. Nature. 339, 439\u2013445 (1989).","journal-title":"Nature"},{"key":"65096_CR4","doi-asserted-by":"publisher","first-page":"13472","DOI":"10.1016\/S0021-9258(18)77371-7","volume":"265","author":"K Otsu","year":"1990","unstructured":"Otsu, K. et al. Molecular cloning of cDNA encoding the Ca2+ release channel (ryanodine receptor) of rabbit cardiac muscle sarcoplasmic reticulum. J. Biol. Chem. 265, 13472\u201313483 (1990).","journal-title":"J. Biol. Chem."},{"key":"65096_CR5","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1083\/jcb.128.5.893","volume":"128","author":"G Giannini","year":"1995","unstructured":"Giannini, G., Conti, A., Mammarella, S., Scrobogna, M. & Sorrentino, V. The ryanodine receptor\/calcium channel genes are widely and differentially expressed in murine brain and peripheral tissues. J. Cell Biol. 128, 893\u2013904 (1995).","journal-title":"J. Cell Biol."},{"key":"65096_CR6","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1002\/humu.20356","volume":"27","author":"R Robinson","year":"2006","unstructured":"Robinson, R., Carpenter, D., Shaw, M. A., Halsall, J. & Hopkins, P. J. H. m. Mutations in RYR1 in malignant hyperthermia and central core disease. Hum. Mutat. 27, 977\u2013989 (2006).","journal-title":"Hum. Mutat."},{"key":"65096_CR7","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1097\/00000542-199606000-00014","volume":"84","author":"V Tegazzin","year":"1996","unstructured":"Tegazzin, V., Scutari, E., Treves, S. & Zorzato, F. J. A. Chlorocresol, an additive to commercial succinylcholine, induces contracture of human malignant hyperthermia-susceptible muscles via activation of the ryanodine receptor Ca2+ channel. Anesthesiology. 84, 1380\u20131385 (1996).","journal-title":"Anesthesiology"},{"key":"65096_CR8","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/S0002-9343(98)00108-9","volume":"104","author":"J Loke","year":"1998","unstructured":"Loke, J. & MacLennan, D. H. Malignant hyperthermia and central core disease: disorders of Ca2 Release Channels1. Am. J. Med. 104, 470\u2013486 (1998).","journal-title":"Am. J. Med."},{"key":"65096_CR9","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1097\/00000542-198204000-00005","volume":"56","author":"ME Kolb","year":"1982","unstructured":"Kolb, M. E., Horne, M. & Martz, R. J. A. Dantrolene in human malignant hyperthermia. Anesthesiology. 56, 254\u2013262 (1982).","journal-title":"Anesthesiology"},{"key":"65096_CR10","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/j.1365-2044.2004.03658.x","volume":"59","author":"T Krause","year":"2004","unstructured":"Krause, T., Gerbershagen, M., Fiege, M., Weisshorn, R. & Wappler, F. J. A. Dantrolene\u2013a review of its pharmacology, therapeutic use and new developments. Anaesthsia. 59, 364\u2013373 (2004).","journal-title":"Anaesthsia"},{"key":"65096_CR11","doi-asserted-by":"publisher","first-page":"34918","DOI":"10.1074\/jbc.M205487200","volume":"277","author":"K Paul-Pletzer","year":"2002","unstructured":"Paul-Pletzer, K. et al. Identification of a dantrolene-binding sequence on the skeletal muscle ryanodine receptor. J. Biol. Chem. 277, 34918\u201334923 (2002).","journal-title":"J. Biol. Chem."},{"key":"65096_CR12","doi-asserted-by":"publisher","first-page":"13810","DOI":"10.1074\/jbc.M006104200","volume":"276","author":"F Zhao","year":"2001","unstructured":"Zhao, F., Li, P., Chen, S. R., Louis, C. F. & Fruen, B. R. Dantrolene inhibition of ryanodine receptor Ca2+ release channels: molecular mechanism and isoform selectivity. J. Biol. Chem. 276, 13810\u201313816 (2001).","journal-title":"J. Biol. Chem."},{"key":"65096_CR13","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1124\/mol.119.116475","volume":"96","author":"G Diszh\u00e1zi","year":"2019","unstructured":"Diszh\u00e1zi, G. et al. Dantrolene requires Mg2+ and ATP to inhibit the ryanodine receptor. Mol. Pharm. 96, 401\u2013407 (2019).","journal-title":"Mol. Pharm."},{"key":"65096_CR14","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1124\/mol.115.097691","volume":"88","author":"YW Oo","year":"2015","unstructured":"Oo, Y. W. et al. Essential role of calmodulin in RyR inhibition by dantrolene. Mol. Pharm. 88, 57\u201363 (2015).","journal-title":"Mol. Pharm."},{"key":"65096_CR15","first-page":"2579","volume":"74","author":"S Kobayashi","year":"2010","unstructured":"Kobayashi, S. et al. Dantrolene, a therapeutic agent for malignant hyperthermia, inhibits catecholaminergic polymorphic ventricular tachycardia in a RyR2R2474S\/+ knock-in mouse model. Circ. 74, 2579\u20132584 (2010).","journal-title":"Circ."},{"key":"65096_CR16","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1016\/j.jacc.2009.01.065","volume":"53","author":"S Kobayashi","year":"2009","unstructured":"Kobayashi, S. et al. Dantrolene, a therapeutic agent for malignant hyperthermia, markedly improves the function of failing cardiomyocytes by stabilizing interdomain interactions within the ryanodine receptor. JACC. 53, 1993\u20132005 (2009).","journal-title":"JACC."},{"key":"65096_CR17","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1161\/CIRCRESAHA.109.209312","volume":"106","author":"H Uchinoumi","year":"2010","unstructured":"Uchinoumi, H. et al. Catecholaminergic polymorphic ventricular tachycardia is caused by mutation-linked defective conformational regulation of the ryanodine receptor. Circ. Res. 106, 1413\u20131424 (2010).","journal-title":"Circ. Res."},{"key":"65096_CR18","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1002\/emmm.201100194","volume":"4","author":"CB Jung","year":"2012","unstructured":"Jung, C. B. et al. Dantrolene rescues arrhythmogenic RYR2 defect in a patient-specific stem cell model of catecholaminergic polymorphic ventricular tachycardia. EMBO Mol. Med. 4, 180\u2013191 (2012).","journal-title":"EMBO Mol. Med."},{"key":"65096_CR19","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/S0016-5085(77)80141-8","volume":"72","author":"R Utili","year":"1977","unstructured":"Utili, R., Boitnott, J. K. & Zimmerman, H. J. J. G. Dantrolene-associated hepatic injury: incidence and character. Gastroenterol. 72, 610\u2013616 (1977).","journal-title":"Gastroenterol"},{"key":"65096_CR20","doi-asserted-by":"publisher","first-page":"152560","DOI":"10.1016\/j.tox.2020.152560","volume":"443","author":"R Jia","year":"2020","unstructured":"Jia, R., Oda, S. & Yokoi, T. J. T. Pharmacological evidence for the involvement of ryanodine receptors in halothane-induced liver injury in mice. Toxicol. 443, 152560 (2020).","journal-title":"Toxicol."},{"key":"65096_CR21","first-page":"796","volume":"82","author":"SM Karan","year":"1996","unstructured":"Karan, S. M. et al. Intravenous lecithin-coated microcrystals of dantrolene are effective in the treatment of malignant hyperthermia: an investigation in rats, dogs, and swine. Anesth. Analg. 82, 796\u2013802 (1996).","journal-title":"Anesth. Analg."},{"key":"65096_CR22","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1097\/00000542-199201000-00019","volume":"76","author":"P Allen","year":"1992","unstructured":"Allen, P., Lopez, J., Sanchez, V., Ryan, J. & Sreter, F. J. A. EU 4093 decreases intracellular [Ca2+] in skeletal muscle fibers from control and malignant hyperthermia-susceptible swine. Anesthesiology. 76, 132\u2013138 (1992).","journal-title":"Anesthesiology"},{"key":"65096_CR23","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1111\/j.1476-5381.1989.tb12573.x","volume":"97","author":"GC Leslie","year":"1989","unstructured":"Leslie, G. C. & Part, N. J. The effect of EU4093 (azumolene sodium) on the contraction of intrafusal muscle in the soleus muscle of the anaesthetized rat. Br. J. Pharm. 97, 1151\u20131156 (1989).","journal-title":"Br. J. Pharm."},{"key":"65096_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms8947","volume":"6","author":"Z Yuchi","year":"2015","unstructured":"Yuchi, Z. et al. Crystal structures of ryanodine receptor SPRY1 and tandem-repeat domains reveal a critical FKBP12 binding determinant. Nat. Commun. 6, 7947 (2015).","journal-title":"Nat. Commun."},{"key":"65096_CR25","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/j.str.2022.04.010","volume":"30","author":"Z Melville","year":"2022","unstructured":"Melville, Z. et al. A drug and ATP binding site in type 1 ryanodine receptor. Structure. 30, 1025\u20131034.e4 (2022).","journal-title":"Structure"},{"key":"65096_CR26","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.str.2024.11.018","volume":"33","author":"KA Iyer","year":"2025","unstructured":"Iyer, K. A., Kobayashi, T., Murayama, T. & Sams\u00f3, M. J. S. Dantrolene inhibition of ryanodine receptor 1 carrying the severe malignant hyperthermia mutation Y522S visualized by cryo-EM. Structure. 33, 338\u2013348 (2025).","journal-title":"Structure"},{"key":"65096_CR27","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1124\/mol.117.111468","volume":"94","author":"T Murayama","year":"2018","unstructured":"Murayama, T. et al. Efficient high-throughput screening by endoplasmic reticulum Ca2+ measurement to identify inhibitors of ryanodine receptor Ca2+-release channels. Mol. Pharm. 94, 722\u2013730 (2018).","journal-title":"Mol. Pharm."},{"key":"65096_CR28","doi-asserted-by":"publisher","first-page":"26965","DOI":"10.1074\/jbc.272.43.26965","volume":"272","author":"BR Fruen","year":"1997","unstructured":"Fruen, B. R., Mickelson, J. R. & Louis, C. F. J. J.oB. C. Dantrolene inhibition of sarcoplasmic reticulum Ca2+ release by direct and specific action at skeletal muscle ryanodine receptors. J. Biol. Chem. 272, 26965\u201326971 (1997).","journal-title":"J. Biol. Chem."},{"key":"65096_CR29","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1021\/bi001502s","volume":"40","author":"K Paul-Pletzer","year":"2001","unstructured":"Paul-Pletzer, K., Palnitkar, S. S., Jimenez, L. S., Morimoto, H. & Parness, J. J. B. The skeletal muscle ryanodine receptor identified as a molecular target of [3H] azidodantrolene by photoaffinity labeling. Biochem. 40, 531\u2013542 (2001).","journal-title":"Biochem."},{"key":"65096_CR30","doi-asserted-by":"publisher","DOI":"10.1085\/jgp.202213277","volume":"155","author":"K Walweel","year":"2023","unstructured":"Walweel, K., Beard, N., van Helden, D. F. & Laver, D. R. Dantrolene inhibition of ryanodine channels (RyR2) in artificial lipid bilayers depends on FKBP12. 6. J. Gen. Physiol. 155, e202213277 (2023).","journal-title":"J. Gen. Physiol."},{"key":"65096_CR31","doi-asserted-by":"publisher","first-page":"H720","DOI":"10.1152\/ajpheart.00103.2023","volume":"325","author":"SA George","year":"2023","unstructured":"George, S. A. et al. Ryanodine receptor inhibition with acute dantrolene treatment reduces arrhythmia susceptibility in human hearts. Am. J. Physiol. Heart Circ. Physiol. 325, H720\u2013H728 (2023).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"65096_CR32","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1097\/WAD.0000000000000075","volume":"29","author":"Z Wu","year":"2015","unstructured":"Wu, Z. et al. Long-term dantrolene treatment reduced intraneuronal amyloid in aged Alzheimer triple transgenic mice. Alzheimer Dis. Assoc. Disord. 29, 184\u2013191 (2015).","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"65096_CR33","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.3233\/JAD-200227","volume":"76","author":"Y Shi","year":"2020","unstructured":"Shi, Y. et al. Intranasal dantrolene as a disease-modifying drug in Alzheimer 5XFAD mice. Alzheimer Dis. Assoc. Disord. 76, 1375\u20131389 (2020).","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"65096_CR34","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1097\/ALN.0000000000003224","volume":"132","author":"Y Wang","year":"2020","unstructured":"Wang, Y. et al. Dantrolene ameliorates impaired neurogenesis and synaptogenesis in induced pluripotent stem cell lines derived from patients with Alzheimer\u2019s disease. Anesthesiology. 132, 1062 (2020).","journal-title":"Anesthesiology"},{"key":"65096_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-52998-9","volume":"15","author":"YS Chen","year":"2024","unstructured":"Chen, Y. S. et al. Cryo-EM investigation of ryanodine receptor type 3. Nat. Commun. 15, 8630 (2024).","journal-title":"Nat. Commun."},{"key":"65096_CR36","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1038\/s41589-020-0627-5","volume":"16","author":"R Ma","year":"2020","unstructured":"Ma, R. et al. Structural basis for diamide modulation of ryanodine receptor. Nat. Chem. Biol. 16, 1246\u20131254 (2020).","journal-title":"Nat. Chem. Biol."},{"key":"65096_CR37","volume":"354","author":"W Peng","year":"2016","unstructured":"Peng, W. et al. Structural basis for the gating mechanism of the type 2 ryanodine receptor RyR2. Scie 354, aah5324 (2016).","journal-title":"Scie"},{"key":"65096_CR38","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1085\/jgp.118.4.355","volume":"118","author":"P Szentesi","year":"2001","unstructured":"Szentesi, P. et al. Effects of dantrolene on steps of excitation-contraction coupling in mammalian skeletal muscle fibers. J. gen. physiol. 118, 355\u2013376 (2001).","journal-title":"J. gen. physiol."},{"key":"65096_CR39","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/0014-2999(90)94788-Y","volume":"178","author":"O Toshio","year":"1990","unstructured":"Toshio, O., Shigeo, I. & Akira, O. J. E. j.o.p. Inhibitory action of dantrolene on Ca-induced Ca2+ release from sarcoplasmic reticulum in guinea pig skeletal muscle. Eur. J. Pharm. 178, 11\u201319 (1990).","journal-title":"Eur. J. Pharm."},{"key":"65096_CR40","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1021\/jm9805079","volume":"42","author":"SS Palnitkar","year":"1999","unstructured":"Palnitkar, S. S. et al. 3H] Azidodantrolene: synthesis and use in identification of a putative skeletal muscle dantrolene binding site in sarcoplasmic reticulum. J. Med. Chem. 42, 1872\u20131880 (1999).","journal-title":"J. Med. Chem."},{"key":"65096_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-51791-y","volume":"15","author":"MC Miotto","year":"2024","unstructured":"Miotto, M. C. et al. Structural basis for ryanodine receptor type 2 leak in heart failure and arrhythmogenic disorders. Nat. Commun. 15, 8080 (2024).","journal-title":"Nat. Commun."},{"key":"65096_CR42","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abo1272","volume":"8","author":"MC Miotto","year":"2022","unstructured":"Miotto, M. C. et al. Structural analyses of human ryanodine receptor type 2 channels reveal the mechanisms for sudden cardiac death and treatment. Sci. Adv. 8, eabo1272 (2022).","journal-title":"Sci. Adv."},{"key":"65096_CR43","doi-asserted-by":"crossref","unstructured":"Kim, K. et al. Structural identification of the RY12 domain of RyR1 as an ADP sensor and the target of the malignant hyperthermia therapeutic dantrolene. bioRxiv. (2024).","DOI":"10.1101\/2024.10.21.619409"},{"key":"65096_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-30429-x","volume":"13","author":"T Kobayashi","year":"2022","unstructured":"Kobayashi, T. et al. Molecular basis for gating of cardiac ryanodine receptor explains the mechanisms for gain-and loss-of function mutations. Nat. Commun. 13, 2821 (2022).","journal-title":"Nat. Commun."},{"key":"65096_CR45","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1038\/s42003-024-06787-1","volume":"7","author":"T Murayama","year":"2024","unstructured":"Murayama, T. et al. Dual role of the S5 segment in type 1 ryanodine receptor channel gating. Commun. Biol. 7, 1108 (2024).","journal-title":"Commun. Biol."},{"key":"65096_CR46","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0091-679X(08)61108-5","volume":"40","author":"DM Bers","year":"1994","unstructured":"Bers, D. M., Patton, C. W. & Nuccitelli, R. J. M. i.c.b. A practical guide to the preparation of Ca2+ buffers. Method Cell Biol. 40, 3\u201329 (1994).","journal-title":"Method Cell Biol."},{"key":"65096_CR47","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1107\/S0907444909052925","volume":"66","author":"PD Adams","year":"2010","unstructured":"Adams, P. D. et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr D. Biol. Crystallogr. 66, 213\u2013221 (2010).","journal-title":"Acta Crystallogr D. Biol. Crystallogr."},{"key":"65096_CR48","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1107\/S0907444904019158","volume":"60","author":"P Emsley","year":"2004","unstructured":"Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr D. Biol. Crystallogr. 60, 2126\u20132132 (2004).","journal-title":"Acta Crystallogr D. Biol. Crystallogr."},{"key":"65096_CR49","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen, E. F. et al. UCSF Chimera\u2014a visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605\u20131612 (2004).","journal-title":"J. Comput. Chem."},{"key":"65096_CR50","doi-asserted-by":"crossref","unstructured":"Schr\u00f6dinger, L.J.S.S. Schr\u00f6dinger, LLC; New York, NY: 2015. (2017).","DOI":"10.1063\/pt.5.031026"},{"key":"65096_CR51","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1021\/acs.jctc.5b00864","volume":"12","author":"E Harder","year":"2016","unstructured":"Harder, E. et al. OPLS3: a force field providing broad coverage of drug-like small molecules and proteins. J. Chem. Theory Comput. 12, 281\u2013296 (2016).","journal-title":"J. Chem. Theory Comput."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-65096-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-65096-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-65096-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,23]],"date-time":"2025-11-23T02:02:32Z","timestamp":1763863352000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-65096-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,18]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["65096"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-65096-1","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,18]]},"assertion":[{"value":"25 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10110"}}